Diagnosis and treatment of myocarditis: The role of endomyocardial biopsy

Current Treatment Options in Cardiovascular Medicine

Volumn 9, Issue 6, 2007, Pages 473-481

  Karatolios, Konstantinos ^b   Pankuweit, Sabine ^b   Maisch, Bernhard ^a  

^a UNIVERSITY HOSPITAL MARBURG   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; ALPHA INTERFERON; ANTIARRHYTHMIC AGENT; ANTIVIRUS AGENT; AZATHIOPRINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA INTERFERON; COLCHICINE; CORTICOSTEROID; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENT; INTERFERON BETA SERINE; LIVE VACCINE; MEASLES VACCINE; MUMPS VACCINE; PLACEBO; PREDNISOLONE; PREDNISONE; RUBELLA VACCINE;

ACUTE HEART FAILURE; ADENOVIRUS; ALGORITHM; APOPTOSIS; ASEPTIC MENINGITIS; ASSISTED CIRCULATION; ASTHENIA; AUTOIMMUNE DISEASE; BACKACHE; CARDIOGENIC SHOCK; CELL INFILTRATION; CLINICAL TRIAL; CONGESTIVE CARDIOMYOPATHY; CREATININE BLOOD LEVEL; CREUTZFELDT JAKOB DISEASE; DEPRESSION; DISEASE COURSE; DRUG ANTAGONISM; DRUG CONTRAINDICATION; DRUG COST; DRUG DOSE INCREASE; DRUG FEVER; DRUG HYPERSENSITIVITY; DRUG INDUCED HEADACHE; DRUG POTENTIATION; DRUG SAFETY; DRUG TARGETING; FLU LIKE SYNDROME; GIANT CELL; HEART ASSIST DEVICE; HEART MUSCLE BIOPSY; HEART MUSCLE INJURY; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FUNCTION; HEMOLYSIS; HISTOPATHOLOGY; HOSPITALIZATION; HUMAN; IMMUNOHISTOCHEMISTRY; INFECTION; INJECTION SITE NECROSIS; INJECTION SITE REACTION; LEUKOCYTE; LEUKOPENIA; MOLECULAR GENETICS; MONOTHERAPY; MYOCARDITIS; NAUSEA AND VOMITING; PARVOVIRUS; PERICARDIAL EFFUSION; PERSISTENT INFECTION; POLYMERASE CHAIN REACTION; REVIEW; SARCOIDOSIS; SIDE EFFECT; SUICIDAL IDEATION; SYMPTOMATOLOGY; THROMBOSIS; TREATMENT INDICATION; VIRUS GENOME; VIRUS MYOCARDITIS;

EID: 36749045874     PISSN: 10928464     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11936-007-0042-1     Document Type: Review

References (37)

1. Richardson P, McKenna W, Bristow M, et al.: Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies. Circulation 1996, 93:841-842.
2. Maisch B, Bültman B, Factor S, et al.: World Heart Federation consensus conferences' definition of inflammatory cardiomyopathy (myocarditis): report from two expert committees on histology and viral cardiomyopathy. Heartbeat 1999, 4:3-4.
3. Pankuweit S, Portig I, Eckhardt H, et al.: Prevalence of viral genome in endomyocardial biopsies from patients with inflammatory heart muscle disease. Herz 2000, 25:221-226.
4. Fujioka S, Kitaura Y, Ukimura A, et al.: Evaluation of viral infection in the myocardium of patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 2000, 36:1920-1926.
5. Pankuweit S, Baandrup U, Moll R, et al.: Prevalence of parvovirus B19 genome in endomyocardial biopsy specimen. Hum Pathol 2003, 34:80-86.
6. Kühl U, Pauschinger M, Bock T, et al.: Parvovirus B19 infection mimicking acute myocardial infarction. Circulation 2003, 108:945-950.
7. Kühl U, Pauschinger M, Noutsias M, et al.: High prevalence of viral genomes and multiple viral infections in the myocardium of adults with "idiopathic" left ventricular dysfunction. Circulation 2005, 111:887-893.
8. Kühl U, Pauschinger M, Seeberg B, et al.: Viral persistence in the myocardium is associated with progressive cardiac dysfunction. Circulation 2005, 112:1965-1970.
9. Maisch B, Richter A, Koelsch S, et al.: Management of patients with suspected (peri-) myocarditis and inflammatory dilated cardiomyopathy. Herz 2006, 31:881-890.
10. Maisch B, Ristic A, Hufnagel G, et al.: Pathophysiology of viral myocarditis. The role of humoral immune response. Cardiovasc Pathol 2002, 11:112-122.
11. Pankuweit S, Ruppert V, Maisch B: Inflammation in dilated cardiomyopathy. Herz 2004, 29:788-793.
12. Mason JW: Myocarditis and dilated cardiomyopathy: an inflammatory link. Cardiovasc Res 2003, 60:5-10.
13. Aretz HT, Billingham ME, Edwards WD, et al.: Myocarditis: a histopathologic definition and classification. Am J Cardiovasc Pathol 1987, 1:3-14.
14. Matsumori A: Hepatitis C virus and cardiomyopathy. Herz 2000, 25:249-254.
15. Matsumori A, Yutani C, Ikeda Y, et al.: Hepatitis C virus from the hearts of patients with myocarditis and cardiomyopathy. Lab Invest 2000, 80:1137-1142.
16. Matsumori A: Role of hepatitis C virus in cardiomyopathies. Ernst Schering Res Found Workshop 2006, 55:99-120.
17. Drory Y, Turetz Y, Hiss Y, et al.: Sudden unexpected death in persons less than 40 years of age. Am J Cardiol 1991, 68:1388-1392.
18. Constanzo-Nordin MR, O'Connell JB, Subramanian R, et al.: Myocarditis confirmed by biopsy presenting as acute myocardial infarction. Br Heart J 1985, 53:25-29.
19. Lauer B, Niederau C, Kuhl U, et al.: Cardiac troponin T in patients with clinically suspected myocarditis. J Am Coll Cardiol 1997, 30:1354-1359.
20. Karjalainen J, Viitasalo M, Kala R, et al.: 24-hour electrocardiographic recordings in mild acute infectious myocarditis. Ann Clin Res 1984, 16:34-39.
21. Tai YT, Lau CP, Fong PC, et al.: Incessant automatic ventricular tachycardia complicating acute Coxsackie B myocarditis. Cardiology 1992, 30:339-344.
22. Friedrich MG, Strohm O, Schulz-Menger J, et al.: Contrast media-enhanced magnetic resonance imaging visualizes myocardial changes in the course of viral myocarditis. Circulation 1998, 97:1802-1809.
23. Ilback NG, Fohlman J, Friman G: Exercise in Coxsackie B3 myocarditis: effects on heart lymphocyte subpopulations and the inflammatory reaction. Am Heart J 1989, 117:1298-1302.
24. Hosenpud JD, Campbell SM, Niles NR, et al.: Exercise induced augmentation of cellular and humoral autoimmunity associated with increased cardiac dilatation in experimental autoimmune myocarditis. Cardiovasc Res 1987, 21:217-222.
25. Takeda Y, Yasuda S, Miyazaki S, et al.: High-dose immunoglobulin G therapy for fulminant myocarditis. Jap Circ J 1998, 62:871-872.
26. Nigro G, Bastianon V, Coloridi V, et al.: Human parvovirus B19 infection in infancy with acute and chronic lymphocytic myocarditis and high cytokine levels: report of 3 cases and review. Clin Infect Dis 2000, 31:65-69.
27. Shioji K, Matsuura Y, Iwase T, et al.: Successful immunoglobulin treatment for fulminant myocarditis and serial analysis of serum thioredoxin: a case report. Circulation J 2002, 66:977-980.
28. Drucker NA, Coland SD, Lewis AB, et al.: Gammaglobulin treatment of acute myocarditis in the pediatric population. Circulation 1994, 89:252-257.
29. McNamara DM, Rosenblum WD, Janosko KM, et al.: Intravenous immune globulin in the therapy of myocarditis and acute cardiomyopathy. Circulation 1997, 95:2476-2478.
30. McNamara DM, Holubkov R, Randall CS, et al.: Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy. Circulation 2001, 103:2254-2259.
31. Maisch B, Hufnagel G, Kölsch S, et al.: Treatment of inflammatory dilated cardiomyopathy and (peri) myocarditis with immunosuppression and intravenous immunoglobulins. Herz 2004, 29:624-636.
32. Maisch B, Hufnagel G, Schoenian U, Hengstenberg C: The European Study of Epidemiology and Treatment of Cardiac Inflammatory Diseases (ESETCID). Eur Heart J 1995, 16(Suppl O):173-175.
33. Hufnagel G, Pankuweit S, Richter A, et al.: The European Study of Epidemiology and Treatment of Cardiac Inflammatory Diseases (ESETCID). First epidemiological results. Herz 2000, 25:279-285.
34. Kühl U, Paischinger M, Schwimmbeck PL, et al.: Interferonbeta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction. Circulation 2003, 107:2793-2798.
35. Mason JW, O'Connell JB, Herskowitz A, et al.: A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. N Engl J Med 1995, 333:269-275.
36. Frustaci A, Chimenti C, Calabrese F, et al.: Immunosuppressive therapy for active lymphocytic myocarditis: virological and immunologic profile of responders versus nonresponders. Circulation 2003, 107:857-863.
37. O'Connell JB, Dec GW, Goldenberg IF, et al.: Results of heart transplantation for active lymphocytic myocarditis. J Heart Transplant 1990, 9:351-356.